Workflow
科创板上市
icon
Search documents
达梦数据高管频被立案背后:高管早有行贿迹象?科创板上市是否埋雷
Xin Lang Zheng Quan· 2025-08-22 04:24
Core Viewpoint - The investigation of senior executives at "China's first domestic database stock" raises concerns about potential bribery and significant violations during the company's listing on the Sci-Tech Innovation Board [2][8] Group 1: Investigation Details - On August 21, 2023, the company announced that its board member and senior vice president Chen Wen is under investigation by the Hubei Provincial Supervisory Committee [2] - On August 19, 2023, the company disclosed that its board member and general manager Pi Yu is also under investigation and has been detained [2] - Both executives have extensive sales backgrounds, with Pi Yu having served in various roles at the company since 2010 and Chen Wen holding similar positions since 2002 [3][7] Group 2: Previous Bribery Allegations - Historical records indicate that the company has faced bribery allegations, with a case involving a payment made to a government official to expedite project payments [6][7] - In 2013, a payment of 50,000 yuan was made to a government official to facilitate the settlement of a project worth 7.26 million yuan [6] Group 3: Company Profile and Financials - The company is a leading developer of database products in China, providing services to large and medium-sized enterprises, government agencies, and institutions [4] - The company's accounts receivable growth significantly outpaces revenue growth, with accounts receivable increasing by 179.73% while revenue grew by 31.49% in the 2024 reporting period [4] Group 4: Listing Concerns - The company went public on the Sci-Tech Innovation Board on June 12, 2024, issuing 19 million shares at a price of 86.96 yuan per share [8] - The investigation of the executives raises questions about potential major violations that could affect the legitimacy of the company's listing [8][9]
飞旋科技筹备科创板上市,董事长洪申平等14名接受辅导人员名单披露
Sou Hu Cai Jing· 2025-08-12 23:45
Core Insights - Tianjin Feixuan Technology Co., Ltd. (Feixuan Technology) has disclosed its progress report on the guidance for its Sci-Tech Innovation Board listing, indicating that the company's performance has not met expectations due to various adverse factors, including macroeconomic conditions and industry competition [2] - Although the company's revenue and profit levels have shown some recovery, they still fall short of the requirements for listing, and the company faces risks related to operational performance fluctuations [2] Company Overview - Feixuan Technology was established in 2012 with a registered capital of 375 million yuan, specializing in providing overall solutions for magnetic levitation high-speed rotating machinery [2] - The company operates under two brands: Feixuan and Yisheng, with Hong Shenping serving as the chairman, general manager, and actual controller [2] Guidance Team - The report discloses the list of individuals receiving guidance, which includes all company directors (including independent directors), supervisors, senior management, and representatives of shareholders holding more than 5% of shares, totaling 14 individuals [2][3] - Key personnel include Hong Jiaping (Chairman, General Manager, Actual Controller), Sha Honglei (Director, Deputy General Manager), and Li Donghui (Director, Board Secretary, Chief Financial Officer) [3]
飞旋科技科创板上市辅导进展:业绩不及预期,尚不满足条件
Sou Hu Cai Jing· 2025-08-12 09:51
Group 1 - The core viewpoint of the article indicates that Tianjin Feixuan Technology Co., Ltd. is facing challenges in meeting the listing conditions on the Sci-Tech Innovation Board due to various adverse factors, including macroeconomic conditions and industry competition [1] - The report reveals that although the company's revenue and profit levels have shown some recovery, they still fall short of the requirements for listing [1] - The company is experiencing operational performance fluctuations and needs to further improve its business performance in the future [1] Group 2 - Feixuan Technology was established in 2012 with a registered capital of 375 million yuan and specializes in providing overall solutions for magnetic levitation high-speed rotating machinery [3] - The company operates under two main brands: Feixuan and Yisheng [3] - The chairman, general manager, and actual controller of the company is Hong Shenping, who holds approximately 50.5% of the shares [3]
刚刚!提交注册26个月后终获注册!科创板第五套标准申报
梧桐树下V· 2025-08-07 14:10
Core Viewpoint - Guangzhou Bibet Pharmaceutical Co., Ltd. has received approval for its IPO on the Sci-Tech Innovation Board after a lengthy registration process, despite reporting no revenue and significant losses over the past three years [2][5]. Group 1: Company Overview - Bibet was established in January 2012 and transitioned to a joint-stock company in December 2021, with a registered capital of approximately 360 million yuan [4]. - The company has one wholly-owned subsidiary and two branch offices, employing a total of 154 staff as of the end of 2024 [4]. Group 2: Financial Performance - The company reported no revenue for the three years from 2022 to 2024, with cumulative losses amounting to 417 million yuan [7]. - The net profit for 2024 is projected at -56 million yuan, a significant reduction from the -172.76 million yuan loss in 2023 [8]. Group 3: Product Development - Bibet focuses on innovative drug development, particularly in oncology, autoimmune diseases, and metabolic disorders, with its core product BEBT-908 already approved for market [5]. - The company has multiple products in various stages of clinical trials, including BEBT-209 in Phase III and BEBT-109 approved for Phase III trials [5]. Group 4: Shareholding Structure - The company has no controlling shareholder, with Qian Changgeng as the actual controller, holding 15.28% of shares directly and controlling an additional 8.59% through a partnership [6]. - Qian Changgeng, the founder, has been instrumental in the company's board composition and holds several key patents [6]. Group 5: IPO and Fundraising - The company plans to raise over 2 billion yuan through its IPO, with 500 million yuan allocated for working capital and the remainder for new drug development and establishing a research center [12]. - The total investment for the new drug development project is estimated at approximately 949.12 million yuan [12]. Group 6: Compliance and Market Position - Bibet meets the Sci-Tech Innovation Board's listing criteria, including having a core product approved for clinical trials and demonstrating significant technological advantages [9][11]. - The company has invested heavily in R&D, with cumulative expenditures exceeding 80 million yuan over the past three years, and a high percentage of its workforce dedicated to R&D [10].
西安奕材8月14日科创板首发上会 拟募资49亿元
Zhong Guo Jing Ji Wang· 2025-08-07 13:47
Core Points - The Shanghai Stock Exchange's Listing Review Committee is scheduled to hold its 31st meeting on August 14, 2025, to review the initial public offering (IPO) of Xi'an Yiswei Material Technology Co., Ltd. [1] - Xi'an Yiswei plans to raise CNY 490 million for the second phase of its silicon industry base project [1] Company Structure - Yiswei Group directly holds 12.73% of Xi'an Yiswei's shares, making it the largest shareholder, while Yiswei Group and its concerted parties control 25.68% of the company [1] - The actual controllers of the company are Wang Dongsheng, Mi Peng, Yang Xinyuan, and Liu Huanping [1] - As of the signing date of the prospectus, the four individuals collectively control 67.92% of the shares of the controlling shareholder, Yiswei Group [1] Underwriting Information - The lead underwriter for Xi'an Yiswei's IPO is CITIC Securities Co., Ltd., with Zhang Huan and Chen Ze as the sponsoring representatives [1]
节卡股份IPO上会前夕被取消审议 拟募资6.76亿元
Zhong Guo Jing Ji Wang· 2025-08-07 13:47
Core Points - The Shanghai Stock Exchange's Listing Review Committee is scheduled to hold its 30th review meeting on August 8, 2025, to assess the application for the initial public offering (IPO) of Jieka Robotics Co., Ltd. on the Sci-Tech Innovation Board [1] - The review meeting has been canceled due to the need for further verification of relevant matters concerning Jieka Robotics [1] - Jieka Robotics plans to raise 67.6 million yuan for projects related to smart robot production and research and development center construction [1] - The lead underwriter for Jieka Robotics is Guotai Junan Securities Co., Ltd., with representatives Yang Chentao and Zhou Litao [1]
集创北方再闯科创板,董事长张晋芳是山西富豪张来栓之子、北交大博士
Sou Hu Cai Jing· 2025-08-06 16:16
Group 1 - The company Beijing Jichuang Beifang Technology Co., Ltd. (referred to as Jichuang Beifang) is planning to conduct an initial public offering (IPO) and list on the Sci-Tech Innovation Board, with CITIC Securities as the advising broker [2]. - Jichuang Beifang was established on September 3, 2008, with a registered capital of 431.065156 million yuan, primarily engaged in the research, design, and sales of display chips [2]. - As of July 31, 2025, the controlling shareholder of the company is Zhang Jinfang, who holds a total equity stake of 39.97% through direct and indirect holdings as well as concerted actions [3]. Group 2 - The company previously submitted an IPO application for the Sci-Tech Innovation Board in June 2022, which was accepted, but it voluntarily withdrew the application in March 2023 [3]. - Zhang Jinfang, the chairman and CEO of Jichuang Beifang, was born in 1985 and graduated with a Ph.D. in Circuit and System from Beijing Jiaotong University. He has held leadership positions in the company since its inception [3]. - Zhang Jinfang's father is the chairman of Shanxi Jiaochangping Energy Group and a wealthy figure in Shanxi, indicating a notable family background [3].
启动上市辅导!集创北方欲二度闯关科创板
Bei Jing Shang Bao· 2025-08-06 02:32
Core Viewpoint - Beijing Jichuang Beifang Technology Co., Ltd. (referred to as "Jichuang Beifang") is attempting to relaunch its IPO on the Sci-Tech Innovation Board after a previous failure, with the support of CITIC Securities as its counseling institution [1][2] Group 1: Company Overview - Jichuang Beifang was established in 2008 and has a registered capital of 431 million yuan [1] - The company focuses on the research, design, and sales of display chips, providing comprehensive solutions for various display panels and screens [1] - The major product lines include panel display driver chips, power management chips, LED display driver chips, and control chips, covering mainstream display technologies such as LCD, LED, OLED, and AR/VR [1] Group 2: Shareholding Structure - As of the report date, the controlling shareholder of Jichuang Beifang is Zhang Jinfang, who holds a total equity stake of 39.97% through direct and indirect holdings [1] Group 3: Technological Advancements - Jichuang Beifang is also expanding into advanced display technology fields such as small-pitch LED displays and silicon-based OLED displays [2] - The company is developing SoC chips and automotive display chips to continuously expand its product line [2]
开盘大涨30%!新三板机器人企业宣布转科创板上市
Sou Hu Cai Jing· 2025-07-31 02:19
Core Viewpoint - Sichuan Tianlian Robot Co., Ltd. (referred to as "Tianlian Robot") experienced a significant stock price increase of 29.63% on July 31, 2023, following its announcement of plans for an initial public offering (IPO) on the Shanghai Stock Exchange's Sci-Tech Innovation Board [1][2]. Financial Performance - The company reported revenues of CNY 21.39 million in 2022 and projected revenues of CNY 29.91 million for 2023, reflecting a year-on-year growth of 39.81% [4]. - The net profit attributable to shareholders was negative, amounting to -CNY 14.27 million for the latest period, an improvement of 23.95% compared to the previous year's loss of -CNY 18.77 million [4]. - The company has a three-year compound annual growth rate (CAGR) of 12.03% in revenue [3]. Company Structure and Control - Tianlian Robot has no controlling shareholder, with the actual controller being Hu Tianlian. The concerted action group, including Hu Tianlian, Wu Jian, and Chen Gang, holds a combined shareholding of 48.53% [3]. Market Position and Future Plans - As of July 30, 2025, the company's total market capitalization was CNY 756 million, which does not meet the financial and market standards required for listing on the Sci-Tech Innovation Board [3]. - The company focuses on developing humanoid robots, collaborative robots, and other advanced robotic technologies, aiming to establish a product layout centered on humanoid robots and supporting technologies [4].
有研复材科创板IPO“已问询” 境外销售收入占比较高
智通财经网· 2025-07-22 00:23
Core Viewpoint - Youyan Composite Materials (Beijing) Co., Ltd. has applied for an IPO on the Shanghai Stock Exchange's Sci-Tech Innovation Board, with a fundraising target of 900 million yuan [1] Group 1: Company Overview - Youyan Composite Materials is a high-tech enterprise primarily engaged in the research, production, and sales of metal composite materials and special non-ferrous metal alloy products [1] - The company's product offerings include metal matrix composite materials, bimetallic composite materials, special aluminum alloy products, and special copper alloy products, which are widely used in aerospace, military electronics, smart terminals, and home appliances [1] Group 2: Revenue Composition - In the fiscal year 2024, the revenue composition is projected to be 72.8% from metal composite materials and 27.2% from special non-ferrous metal alloy products [2] - The company has a significant portion of its sales coming from international markets, with overseas sales accounting for 37.42%, 27.99%, and 21.52% of total revenue in the years 2022, 2023, and 2024, respectively [2] Group 3: Financial Data - The company's projected revenues for the years 2022, 2023, and 2024 are approximately 414 million yuan, 498 million yuan, and 610 million yuan, respectively [3] - The net profits for the same years are estimated to be around 75.11 million yuan, 61.91 million yuan, and 68.44 million yuan, respectively [3] - Total assets as of December 31 for the years 2022, 2023, and 2024 are reported to be 576.36 million yuan, 755.33 million yuan, and 1.088 billion yuan, respectively [5] - The company's equity attributable to shareholders is projected to grow from 307.88 million yuan in 2022 to 745.99 million yuan in 2024 [5] Group 4: Financial Ratios - The debt-to-asset ratio for the parent company is expected to decrease from 38.91% in 2023 to 26.72% in 2024, indicating improved financial stability [7] - The consolidated debt-to-asset ratio is projected to decline from 40.53% in 2023 to 30.97% in 2024 [7]